SIGN INMYPAGE

The Liver Week 2025

  • INTRODUCTION
    • Welcome
    • Organization
    • Information
    • History
  • PROGRAM
    • Program at a Glance
    • Daily Program
    • Invited Faculty
    • Food & Beverage
    • Industry Symposia
  • ABSTRACT
    • Submission Guidelines
    • Presentation Guidelines
    • Award Program
  • REGISTRATION
    • Registration
    • 평점안내
  • VENUE
    • HICO
    • Accommodation
    • Transportation
    • Gyeongju
  • PARTNERSHIP
    • Partnership

PROGRAMThe Liver Week 2025A Big Welcome to the Liver Festival in Gyeongju, Korea!May 29-31, 2025IHICO, Gyeongju, Korea

PROGRAM AT A GLANCE DAILY PROGRAM INVITED FACULTY MEAL PLAN INDUSTRY SYMPOSIA
  • Thursday, May 29, 2025
  • Friday, May 30, 2025
  • Saturday, May 31, 2025
  • ROOM 1[3F]
  • ROOM 2[3F]
  • ROOM 3[2F]
  • ROOM 4[2F]
  • ROOM 6[1F]

*K: Session in Korean

07:30-08:50

KASL Special Interest Group 4. The KASL Viral Hepatitis Study Group
Advancing Insights into HBV Pathogenesis and Therapy

Chair: Hyung Joon Yim (Korea Univ.), Takehisa Watanabe (Kumamoto Univ., Japan)

  • 07:30-08:00
  • Maternal Chronic HBV Infection and Its Potential Impact on Fetal Development and Congenital Anomalies

    Yewan Park (Kyung Hee Univ.)

  • 08:00-08:25
  • A Novel Anti-HBV Compound Reduces HBsAg and HBV-DNA by Destabilizing HBV-RNA

    Takehisa Watanabe (Kumamoto Univ., Japan)

  • 08:25-08:50
  • AI-Based HCC Risk Prediction in Chronic HBV Patients

    Yeonjung Ha (CHA Univ.)

09:10-10:30

KASL-AASLD Joint Symposium 2
Looking into the Future of Hepatology

Chair: Silvia Sookoian (Maimonides Univ., Argentina), Sook-Hyang Jeong (Seoul National Univ.)

  • 09:10-09:30
  • Anti-Fibrotic and Anti-Cirrhotic Approaches in Chronic Liver Disease

    Seung Up Kim (Yonsei Univ.)

  • 09:30-09:50
  • Future Directions in Liver Transplant Allocation Policies: Beyond MELD

    W. Ray Kim (Mayo Clinic, USA)

  • 09:50-10:10
  • Gut Microbiome-Targeted Therapies to Enhance Treatment Outcomes of Liver Diseases

    Ki Tae Suk (Hallym Univ.)

  • 10:10-10:30
  • Molecular and Immunological Biomarkers for Hepatocellular Carcinoma to Guide Personalized Treatment Decisions

    Renumathy Dhanasekaran (Stanford Univ., USA)

  • 10:30-10:50
  • Coffee Break

10:50-11:20

President's Choice Lecture

Chair: Yoon Jun Kim (Seoul National Univ.)

  • 10:50-11:20
  • Management of Portal Hypertension in Advanced Cirrhosis

    Shiv Kumar Sarin (Institute of Liver and Biliary Sciences, India)

11:20-12:20

Plenary Presentation 2

Chair: June Sung Lee (Inje Univ.), Si Hyun Bae (The Catholic Univ. of Korea), Kwang-Woong Lee (Seoul National Univ.)

  • 11:20-11:35
  • Efficacy and Safety of Time-Restricted Eating in Metabolic Dysfunction-Associated Steatotic Liver Disease

    Joo Hyun Oh (CHA Univ.)

  • 11:35-11:50
  • Development of Glypican-3-Targeting CAR-NK Cells with IL-15 Secretion for Hepatocellular Carcinoma Treatment

    Wonseok Kang (Sungkyunkwan Univ.)

  • 11:50-12:05
  • A Novel Risk Prediction Model for Survival in Patients with Autoimmune Hepatitis: A Multicenter Cohort Study

    Soon Kyu Lee (The Catholic Univ. of Korea)

  • 12:05-12:20
  • Outcomes and Key Determinants in Living Donor Liver Transplants from Older Donors: A Multicenter Cohort Analysis

    Eun-Ki Min (Yonsei Univ.)

  • 12:20-13:10
  • Luncheon Symposium 10

13:10-14:30

KASL Symposium 3
Emerging Concepts, Challenges, and Therapeutic Frontiers of Metabolic Dysfunction–Associated Steatotic Liver Disease

Chair: Tatsuya Kanto (Japan Institute for Health Security, Japan), Won Kim (Seoul National Univ.)

  • 13:10-13:30
  • Identification of Genes Conferring Individual-Level Variation Responsible for MASLD Using Single-Cell eQTL Analysis

    Murim Choi (Seoul National Univ.)

  • 13:30-13:50
  • GLP-1 Receptor Agonists in MASLD: Current Clinical Status and Future Directions

    Sang Bong Ahn (Eulji Univ.)

  • 13:50-14:10
  • Resmetirom's Promise and the Challenges Ahead

    Kris V. Kowdley (Washington State Univ., USA)

  • 14:10-14:30
  • New Drug Discovery Based on Multi-Omics

    Silvia Sookoian (Maimonides Univ., Argentina)

14:30-14:50

KASL Leading Research Achievement Award (*K)

  • 14:30-14:50
  • Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

    Seung Up Kim (Yonsei Univ.)

14:50-15:50

The Liver Week 2025 Debrief

Chair: Ju Hyun Shim (KASL), Su Jong Yu (KLCA), Jongman Kim (KAHBPS), Hae Won Lee (KLTS)

  • 14:50-15:05
  • KASL

    Eun Sun Jang (Seoul National Univ.)

  • 15:05-15:20
  • KLCA

    Yuri Cho (National Cancer Center)

  • 15:20-15:35
  • KAHBPS

    Min-Su Park (Kyung Hee Univ.)

  • 15:35-15:50
  • KLTS

    Su Young Hong (Seoul National Univ.)

  • 15:50-16:10
  • Closing & Award Ceremony

07:30-08:50

KLCA Symposium 3
Revisiting and Expanding Hepatocellular Carcinoma Treatment Paradigms: From Standard to Innovative Therapies

Chair: Jong Young Choi (Chung-Ang Univ.), Augusto Villanueva (NYU Langone, USA)

  • 07:30-07:50
  • Systemic Therapy and Transarterial Chemoembolization in BCLC Intermediate Stage: A Survival Boost?

    Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)

  • 07:50-08:10
  • TACE/TARE in Advanced HCC: Can They Coexist with Systemic Therapy?

    Hyo-Cheol Kim (Seoul National Univ.)

  • 08:10-08:30
  • The Emerging Role of Immuno-Oncology Therapy in Neo- and Adjuvant Treatment for HCC

    Jacob George (The Univ. of Sydney, Australia)

  • 08:30-08:50
  • Cancer Vaccines in HCC: Current Status and Future Directions

    Jeong Heo (Pusan National Univ.)

09:10-10:30

KLCA-TLCA Joint Symposium
Innovating and Expanding Surgical Horizons for Hepatocellular Carcinoma in the Immunotherapy Era

Chair: Kyung Sik Kim (Yonsei Univ.), Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)

  • 09:10-09:30
  • Surgical Innovations for Advanced HCC in the Immunotherapy Era: Korean Expertise

    Gi Hong Choi (Yonsei Univ.)

  • 09:30-09:50
  • Advancing Liver Surgery in the Immunotherapy Era: The Taiwanese Experience

    Ming-Chin Yu (Chang Gung Medical Foundation, Taiwan)

  • 09:50-10:10
  • Combining Immunotherapy with Local Treatments: New Directions for HCC Management in Korea

    Yun Bin Lee (Seoul National Univ.)

  • 10:10-10:30
  • Immune Checkpoint Inhibitors and Biomarker Discovery: Tailoring Treatment for HCC

    Chien-Hung Chen (National Taiwan Univ., Taiwan)

  • 12:20-13:10
  • Luncheon Symposium 11

07:30-08:50

KLTS Symposium 1
Living Donor Liver Transplantation-Based Protocol for Hepatocellular Carcinoma: Intention-to-Treat Approach with Pre-Transplant Therapy

Chair: Myoung Soo Kim (Yonsei Univ.), Il Han Song (Dankook Univ.)

  • 07:30-07:50
  • Definition and Current Status of Bridging, Neoadjuvant, Downstaging, and Conversion Therapies

    Moon Haeng Hur (Seoul National Univ.)

  • 07:50-08:10
  • Pros and Cons of Repetitive Transarterial Chemoembolization or Other Locoregional Therapies Prior to Liver Transplantation 

    Dongho Hyun (Sungkyunkwan Univ.)

  • 08:10-08:30
  • Practical Factors Considered in Immunotherapy Prior to Liver Transplantation

    Dong Hyun Sinn (Sungkyunkwan Univ.)

  • 08:30-08:50
  • Lessons for Developing Protocols Based on Real-World Data

    Dong-Hwan Jung (Univ. of Ulsan)

09:10-10:30

KLTS Symposium 2
Technical Hurdles in Living Donor Liver Transplantation

Chair: Dong-Sik Kim (Korea Univ.), Unenbat Gurbadam (National Cancer Center, Mongolia)

  • 09:10-09:30
  • Outflow Reconstruction Tips in Liver Transplant for Budd-Chiari Syndrome

    Gyu-seong Choi (Sungkyunkwan Univ.)

  • 09:30-09:50
  • Portal Vein Reconstruction in a Recipient with Atretic Portal Vein

    Kwang-Woong Lee (Seoul National Univ.)

  • 09:50-10:10
  • Difficult Arterial Reconstruction: Multiple Arteries or Size-Mismatched Situations

    Chul Soo Ahn (Univ. of Ulsan)

  • 10:10-10:30
  • Various Bile Duct Anastomosis Methods for Multiple Duct Situations

    Tae-Seok Kim (Keimyung Univ.)

  • 12:20-13:10
  • Luncheon Symposium 12

13:10-14:30

KLTS Symposium 3
Frontline Approaches in Deceased Donor Liver Transplantation: Optimizing Outcomes with Limited Liver Grafts

Chair: Yang Won Nah (Univ. of Ulsan), Young Kyoung You (The Catholic Univ. of Korea)

  • 13:10-13:30
  • Current Status and Challenges of the Liver Allocation System for Deceased Donors in Korea

    Young-In Yoon (Univ. of Ulsan)

  • 13:30-13:50
  • Patient Selection and Timing of Referral for Liver Transplantation in Acute Alcoholic Hepatitis

    Do Seon Song (The Catholic Univ. of Korea)

  • 13:50-14:10
  • Perioperative Challenges and Solutions for Patients with Chronic Liver Disease Undergoing Deceased Donor Liver Transplantation

    Young Chul Yoon (The Catholic Univ. of Korea)

  • 14:10-14:30
  • Predicting Futile Outcomes in Deceased Donor Liver Transplantation: Focus on Acute-on-Chronic Liver Failure

    YoungRok Choi (Seoul National Univ.)

07:30-08:50

KASL Special Interest Group 5. The KASL Study Group of Portal Hypertension

Advancing the Frontiers of Cirrhosis Care: Diagnostic and Therapeutic Insights

Chair: Young Seok Kim (Soonchunhyang Univ.), Won Hyeok Choe (Konkuk Univ.)

  • 07:30-07:50
  • Optimal Management Strategies for Non-Selective Beta-Blockers in Cirrhosis

    Jae Yoon Jeong (Ewha Womans Univ.)

  • 07:50-08:10
  • Advances in Non-Invasive Methods for Detecting Clinically Significant Portal Hypertension

    Hyunwoo Oh (Sungkyunkwan Univ.)

  • 08:10-08:30
  • Updates in the Management of Acute Kidney Injury in Patients with Cirrhosis

    Sung Hwan Yoo (Yonsei Univ.)

  • 08:30-08:50
  • Optimizing Nutrition in Cirrhosis: Recent Advances and Clinical Implications

    Masahito Shimizu (Gifu Univ., Japan)

09:10-10:30

Data Science Camp 2
Artificial Intelligence in Hepatology

Chair: Jin-Woo Lee (Inha Univ.), Kang Mo Kim (Univ. of Ulsan)

  • 09:10-09:35
  • Hepatic Applications of Artificial Intelligence

    Seung Soo Lee (Univ. of Ulsan)

  • 09:35-10:00
  • Artificial Intelligence for Clinical Prediction

    Beom Kyung Kim (Yonsei Univ.)

  • 10:00-10:30
  • Imaging Reconstruction for AI Models

    Jong Chul Ye (KAIST)

  • 12:20-13:10
  • Luncheon Symposium 13

13:10-14:50

KASL Symposium 4
Integrative Approaches to Alcohol-Related Hepatic Disorders

Chair: Dominique Damais-Thabut (Sorbonne Univ., France), Sang Gyune Kim (Soonchunhyang Univ.)

  • 13:10-13:30
  • Sex and Gender Differences in Alcohol-Associated Liver Disease

    Young Chang (Soonchunhyang Univ.)

  • 13:30-13:50
  • Altered Mental Status in Alcoholic Cirrhosis: Etiologies Other Than Hepatic Encephalopathy

    Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India)

  • 13:50-14:10
  • Emerging Regimens Competing with Glucocorticoids for Severe Alcoholic Hepatitis

    Sumeet Asrani (Baylor Univ., USA)

  • 14:10-14:30
  • Multidisciplinary Approaches to Treat Alcohol-Associated Liver Disease

    Seong Hee Kang (Korea Univ.)

  • 14:30-14:50
  • Specific Management of Portal Hypertension Before and After Liver Transplantation

    Shashwat Sarin (Max Hospital, India)

07:30-08:50

KASL Special Interest Group 6. The KASL Alcohol-Related Problem Study Group
KASL-BATL Joint Session: Alcohol and Environmental Cues in Liver Disease

Chair: Yoon Mee Yang (Kangwon National Univ.), Wonhyo Seo (Ewha Womans Univ.)

  • 07:30-07:50
  • Hepatic Glutamate Signaling Pathway in Alcohol-Associated Liver Disease

    Won-Il Jeong (KAIST)

  • 07:50-08:10
  • IRONing Out MASLD: Hepatocyte Messages to Adipose Tissue

    Chang Yeob Han (Jeonbuk National Univ.)

  • 08:10-08:30
  • Calibration of Gut-Liver Axis via Bile Acid and Neutrophils

    Yong-Hyun Han (Kangwon National Univ.)

  • 08:30-08:50
  • Diagnosis and Treatment of Liver Disease Using Extracellular Vesicles

    Shuji Terai (Niigata Univ., Japan)

  • 12:20-13:10
  • Luncheon Symposium 14

The Liver Week 2025

SECRETARIAT OF THE LIVER WEEK 2025

HB&I, #1711, Hanshin Building, Mapo-daero, Mapo-gu, Seoul, Korea, 04175

Tel: +82-2-373-1005    I    Fax: +82-2-373-1106
E-mail: theliverweek@hbni.co.kr

The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero (MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, Korea, 04185

TEL: +82-2-703-0051    I    Fax: +82-2-703-0071
E-mail: kasl@kams.or.kr